Tarsus Pharmaceuticals, Inc. (TARS) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.59 | +48.2% |
| 2024 | $-3.07 | +33.5% |
| 2023 | $-4.62 | -83.3% |
| 2022 | $-2.52 | -276.1% |
| 2021 | $-0.67 | +84.5% |
| 2020 | $-4.32 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.59 | +48.2% |
| 2024 | $-3.07 | +33.5% |
| 2023 | $-4.62 | -83.3% |
| 2022 | $-2.52 | -276.1% |
| 2021 | $-0.67 | +84.5% |
| 2020 | $-4.32 | — |